On November 17, the 2023 China Health Industry Development Conference and the 3rd Golden Cane Award Ceremony, hosted by China Times, was successfully held in Beijing.

As a leading enterprise in the medical aesthetics industry, Imeik was invited to attend the event. With its cutting-edge technology and outstanding R&D achievements, Imeik was selected as one of the “Top 10 Innovative Biotech Enterprises of 2023”, winning the prestigious Golden Cane Award.

Initiated by China Times in 2021, the Golden Cane Award is presented annually to recognize the most influential companies, brands, and products in the pharmaceutical, medical, and broader healthcare sectors. Participating companies span a wide range of areas including medical services (hospitals), pharmaceuticals and medical devices, health foods, supplements, health management, and elderly care. Since July 2023, over 400 companies took part in the competition, which went through five months of applications, nominations, online voting, and expert committee evaluations before the final winners were announced.

Imeik’s standout performance among numerous candidates reflects the industry’s recognition of its leadership in medical aesthetics and its innovation-driven development capabilities.

Through both in-house R&D and external collaborations, Imeik continues to expand its innovative product portfolio—from biomaterials to biopharmaceuticals and chemical medicines. Each product serves a unique function, while maintaining strong synergy across the portfolio to meet the evolving and growing needs of consumers.

Moreover, on November 19, Imeik launched three new skincare brands: IFuyuan, Hearty Skincare, and Hearty Panda Skincare, targeting key areas including facial, neck, and eye care. The company also introduced a full-cycle treatment and product guide under the concept of “aesthetic-therapeutic integration,” with a special focus on the emerging post-procedure recovery market.

Innovation is the driving force behind the high-quality development of the biotech industry. Imeik will continue to uphold its mission of “empowering beauty with science,” further leveraging its advantages in medical aesthetics and accelerating its transformation into a globally competitive Chinese brand.